Literature DB >> 9521273

The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis.

I Torres-Aleman1, V Barrios, J Berciano.   

Abstract

A lack of trophic support may lead to degeneration of adult nerve cells. Several growth factors, including insulin-like growth factor I (IGF-I), control the survival of spinal motor neurons during development as well as after experimental injury. These neurons are selectively affected in patients with amyotrophic lateral sclerosis (ALS). Thus, we analyzed whether reduced levels of circulating IGF-I may be present in this disease. Significant increases were found in three of four of the main circulating IGF-binding proteins in ALS patients, whereas serum IGF-I and insulin levels were significantly reduced. On the contrary, multiple sclerosis patients did not show any significant change in the IGF-I trophic system even though oligodendrocytes are known targets of the trophic action of IGF-I. These results suggest an involvement of the peripheral IGF-I trophic system in ALS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521273     DOI: 10.1212/wnl.50.3.772

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Molecular mechanisms regulating motor neuron development and degeneration.

Authors:  T J Kilpatrick; M Soilu-Hänninen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.

Authors:  Francesco Saccà; Mario Quarantelli; Carlo Rinaldi; Tecla Tucci; Raffaele Piro; Gaetano Perrotta; Barbara Carotenuto; Angela Marsili; Vincenzo Palma; Giuseppe De Michele; Arturo Brunetti; Vincenzo Brescia Morra; Alessandro Filla; Marco Salvatore
Journal:  J Neurol       Date:  2011-06-25       Impact factor: 4.849

Review 3.  Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases.

Authors:  M Gasperi; A E Castellano
Journal:  J Endocrinol Invest       Date:  2010-09       Impact factor: 4.256

Review 4.  Motor neuron-immune interactions: the vicious circle of ALS.

Authors:  Ana G Barbeito; Pinar Mesci; Séverine Boillée
Journal:  J Neural Transm (Vienna)       Date:  2010-06-15       Impact factor: 3.575

Review 5.  Brain repair and neuroprotection by serum insulin-like growth factor I.

Authors:  Eva Carro; Jose Luis Trejo; Angel Núñez; Ignacio Torres-Aleman
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 6.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04

Review 7.  Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.

Authors:  F Sohrabji; M Williams
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

Review 8.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

9.  Immunohistochemical localization of insulin-like growth factor binding protein 2 in the central nervous system of SOD1(G93A) transgenic mice.

Authors:  Sung Eun Sim; Yoon Hee Chung; Ji Hoon Jeong; Sin Weon Yun; Hyoun-Sub Lim; Daejin Kim; Sung Su Kim; Won Bok Lee; Choong Ik Cha
Journal:  J Mol Histol       Date:  2009-05-26       Impact factor: 2.611

Review 10.  Role of insulin-like growth factor I signaling in neurodegenerative diseases.

Authors:  José Luis Trejo; Eva Carro; Eva Garcia-Galloway; Ignacio Torres-Aleman
Journal:  J Mol Med (Berl)       Date:  2003-11-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.